Cargando…
Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
Lymphocytes in tumor tissue are called tumor-infiltrating lymphocytes (TILs), and they play a key role in the control and treatment of tumor diseases. Since the discovery in 1987 that cultured TILs can kill tumor cells more than 100 times more effectively than T-cells cultured from peripheral blood...
Autor principal: | Li, Biaoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635507/ https://www.ncbi.nlm.nih.gov/pubmed/36341370 http://dx.doi.org/10.3389/fimmu.2022.973881 |
Ejemplares similares
-
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
por: Kazemi, Mohammad Hossein, et al.
Publicado: (2022) -
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
por: Wang, Shuhang, et al.
Publicado: (2021) -
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
por: Maibach, Fabienne, et al.
Publicado: (2020) -
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials
por: McCarthy, Patrick M., et al.
Publicado: (2023) -
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
por: Zhao, Yueshui, et al.
Publicado: (2022)